earnings
confidence high
sentiment positive
materiality 0.80
Omada Health Q3 revenue $68M (+49% YoY); first positive adjusted EBITDA $2M
Omada Health, Inc.
2025-Q3 EPS reported
-$0.61
revenue$184,364,000
- Revenue $68M, up 49% YoY; members 831K, up 53% YoY.
- Net loss $3M vs $9M loss prior year; first quarter of positive adjusted EBITDA of $2M.
- Gross margin 66% (non-GAAP 68%), up from 63% (65%) in Q3 2024.
- Announced new GLP-1 prescribing offering combining behavior change with anti-obesity medications.
- Cash and equivalents $199M at quarter end.